Trial
NCT02061007
Biomarker Correlates of Hypoxia in Metastatic Melanoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
—
Condition
Melanoma
Intervention
Pimonidazole hydrochloride (Hypoxyprobe™-1)
Why stopped
no accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-09